HCAT: Health Catalyst Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Health Catalyst Inc (HCAT).
$430.19M Market Cap.
HCAT Market Cap. (MRY)
HCAT Shares Outstanding (MRY)
HCAT Assets (MRY)
Total Assets
$858.93M
Total Liabilities
$493.72M
Total Investments
$142.35M
HCAT Income (MRY)
Revenue
$306.58M
Net Income
-$69.50M
Operating Expense
$210.59M
HCAT Cash Flow (MRY)
CF Operations
$14.56M
CF Investing
-$22.90M
CF Financing
$151.75M
HCAT Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $858,929,000 (22.39%) | $701,814,000 (-6.71%) | $752,286,000 (-9.59%) | $832,096,000 (44.03%) |
Assets Current | $465,650,000 (18.37%) | $393,397,000 (-8.04%) | $427,795,000 (-15.85%) | $508,391,000 (54.15%) |
Assets Non-Current | $393,279,000 (27.52%) | $308,417,000 (-4.95%) | $324,491,000 (0.24%) | $323,705,000 (30.56%) |
Goodwill & Intangible Assets | $345,811,000 (30.97%) | $264,036,000 (-5.08%) | $278,171,000 (1.24%) | $274,760,000 (32.90%) |
Shareholders Equity | $365,207,000 (-0.47%) | $366,919,000 (-13.67%) | $425,010,000 (-18.60%) | $522,098,000 (89.10%) |
Property Plant & Equipment Net | $41,452,000 (4.57%) | $39,639,000 (-6.92%) | $42,586,000 (-4.19%) | $44,449,000 (18.24%) |
Cash & Equivalents | $249,645,000 (134.90%) | $106,276,000 (-8.63%) | $116,312,000 (-39.81%) | $193,227,000 (110.13%) |
Accumulated Other Comprehensive Income | -$835,000 (-2630.30%) | $33,000 (105.09%) | -$648,000 (-867.16%) | -$67,000 (-209.84%) |
Deferred Revenue | $53,530,000 (-4.12%) | $55,830,000 (1.39%) | $55,066,000 (-4.33%) | $57,561,000 (17.42%) |
Total Investments | $142,355,000 (-32.68%) | $211,452,000 (-14.45%) | $247,178,000 (-1.82%) | $251,754,000 (40.71%) |
Investments Current | $142,355,000 (-32.68%) | $211,452,000 (-14.45%) | $247,178,000 (-1.82%) | $251,754,000 (40.71%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $57,182,000 (-5.16%) | $60,290,000 (25.68%) | $47,970,000 (-1.70%) | $48,801,000 (1.05%) |
Trade & Non-Trade Payables | $11,433,000 (72.16%) | $6,641,000 (50.11%) | $4,424,000 (-5.73%) | $4,693,000 (-11.98%) |
Accumulated Retained Earnings (Deficit) | -$1,186,672,000 (-6.22%) | -$1,117,170,000 (-11.83%) | -$999,023,000 (-13.67%) | -$878,860,000 (-21.11%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $402,265,000 (61.51%) | $249,068,000 (0.44%) | $247,974,000 (21.19%) | $204,611,000 (4.78%) |
Debt Current | $234,796,000 (6892.14%) | $3,358,000 (-2.21%) | $3,434,000 (0.26%) | $3,425,000 (30.63%) |
Debt Non-Current | $167,469,000 (-31.84%) | $245,710,000 (0.48%) | $244,540,000 (21.55%) | $201,186,000 (4.42%) |
Total Liabilities | $493,722,000 (47.43%) | $334,895,000 (2.33%) | $327,276,000 (5.57%) | $309,998,000 (2.77%) |
Liabilities Current | $325,850,000 (265.98%) | $89,034,000 (7.91%) | $82,510,000 (-11.33%) | $93,051,000 (5.70%) |
Liabilities Non-Current | $167,872,000 (-31.72%) | $245,861,000 (0.45%) | $244,766,000 (12.82%) | $216,947,000 (1.56%) |
HCAT Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $306,584,000 (3.60%) | $295,938,000 (7.13%) | $276,236,000 (14.18%) | $241,926,000 (28.11%) |
Cost of Revenue | $165,805,000 (1.04%) | $164,105,000 (14.72%) | $143,049,000 (15.03%) | $124,354,000 (26.79%) |
Selling General & Administrative Expense | $111,204,000 (-22.71%) | $143,880,000 (-3.58%) | $149,215,000 (-7.30%) | $160,961,000 (40.39%) |
Research & Development Expense | $57,950,000 (-20.21%) | $72,627,000 (-4.03%) | $75,680,000 (20.64%) | $62,733,000 (17.22%) |
Operating Expenses | $210,585,000 (-18.61%) | $258,730,000 (-5.29%) | $273,192,000 (4.58%) | $261,222,000 (39.77%) |
Interest Expense | -$637,000 (93.00%) | -$9,106,000 (-642.67%) | $1,678,000 (-89.80%) | $16,458,000 (42.22%) |
Income Tax Expense | $333,000 (-6.46%) | $356,000 (108.32%) | -$4,280,000 (37.95%) | -$6,898,000 (-477.72%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$69,502,000 (41.17%) | -$118,147,000 (14.01%) | -$137,403,000 (10.32%) | -$153,210,000 (-33.21%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$69,502,000 (41.17%) | -$118,147,000 (14.01%) | -$137,403,000 (10.32%) | -$153,210,000 (-33.21%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$69,502,000 (41.17%) | -$118,147,000 (14.01%) | -$137,403,000 (10.32%) | -$153,210,000 (-33.21%) |
Weighted Average Shares | $60,185,000 (6.68%) | $56,418,000 (5.02%) | $53,722,000 (13.11%) | $47,495,000 (20.12%) |
Weighted Average Shares Diluted | $60,185,000 (6.68%) | $56,418,000 (4.32%) | $54,080,000 (13.86%) | $47,495,000 (20.12%) |
Earning Before Interest & Taxes (EBIT) | -$69,806,000 (44.99%) | -$126,897,000 (9.36%) | -$140,005,000 (2.54%) | -$143,650,000 (-37.28%) |
Gross Profit | $140,779,000 (6.79%) | $131,833,000 (-1.02%) | $133,187,000 (13.28%) | $117,572,000 (29.53%) |
Operating Income | -$69,806,000 (44.99%) | -$126,897,000 (9.36%) | -$140,005,000 (2.54%) | -$143,650,000 (-49.44%) |
HCAT Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$22,902,000 (-212.86%) | $20,293,000 (152.01%) | -$39,021,000 (72.06%) | -$139,678,000 (-69.17%) |
Net Cash Flow from Financing | $151,746,000 (5458.46%) | $2,730,000 (204.48%) | -$2,613,000 (-100.99%) | $264,084,000 (44.62%) |
Net Cash Flow from Operations | $14,559,000 (144.01%) | -$33,080,000 (6.21%) | -$35,270,000 (-52.53%) | -$23,123,000 (11.57%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $143,369,000 (1528.55%) | -$10,036,000 (86.95%) | -$76,915,000 (-175.95%) | $101,273,000 (37.00%) |
Net Cash Flow - Business Acquisitions and Disposals | -$80,277,000 (-604.68%) | -$11,392,000 (59.09%) | -$27,846,000 (40.45%) | -$46,763,000 (54.00%) |
Net Cash Flow - Investment Acquisitions and Disposals | $73,760,000 (60.47%) | $45,965,000 (640.18%) | $6,210,000 (108.34%) | -$74,470,000 (-352.07%) |
Capital Expenditure | -$15,877,000 (-20.63%) | -$13,162,000 (12.98%) | -$15,125,000 (11.40%) | -$17,072,000 (-85.50%) |
Issuance (Repayment) of Debt Securities | $149,166,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $2,580,000 (-5.49%) | $2,730,000 (314.79%) | -$1,271,000 (-100.47%) | $270,374,000 (566.98%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$34,000 (-261.90%) | $21,000 (290.91%) | -$11,000 (-10.00%) | -$10,000 (-138.46%) |
Share Based Compensation | $40,128,000 (-28.03%) | $55,756,000 (-22.67%) | $72,104,000 (10.68%) | $65,145,000 (71.63%) |
Depreciation Amortization & Accretion | $44,116,000 (-2.43%) | $45,213,000 (-12.26%) | $51,528,000 (25.33%) | $41,113,000 (78.53%) |
HCAT Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 45.90% (3.15%) | 44.50% (-7.68%) | 48.20% (-0.82%) | 48.60% (1.04%) |
Profit Margin | -22.70% (43.11%) | -39.90% (19.72%) | -49.70% (21.48%) | -63.30% (-3.94%) |
EBITDA Margin | -8.40% (69.57%) | -27.60% (13.75%) | -32.00% (24.53%) | -42.40% (1.85%) |
Return on Average Equity (ROAE) | -19.40% (36.60%) | -30.60% (5.26%) | -32.30% (-10.24%) | -29.30% (29.74%) |
Return on Average Assets (ROAA) | -9.10% (44.51%) | -16.40% (10.38%) | -18.30% (0.54%) | -18.40% (7.54%) |
Return on Sales (ROS) | -22.80% (46.85%) | -42.90% (15.38%) | -50.70% (14.65%) | -59.40% (-7.22%) |
Return on Invested Capital (ROIC) | -25.50% (-1.19%) | -25.20% (5.97%) | -26.80% (11.26%) | -30.20% (-11.44%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -6.15 (-38.75%) | -4.43 (-6.72%) | -4.15 (66.15%) | -12.27 (18.00%) |
Price to Sales Ratio (P/S) | 1.39 (-21.36%) | 1.76 (-14.61%) | 2.07 (-73.43%) | 7.78 (-14.66%) |
Price to Book Ratio (P/B) | 1.18 (-18.87%) | 1.45 (6.06%) | 1.37 (-65.34%) | 3.95 (-41.04%) |
Debt to Equity Ratio (D/E) | 1.35 (48.08%) | 0.91 (18.57%) | 0.77 (29.63%) | 0.59 (-45.65%) |
Earnings Per Share (EPS) | -1.15 (44.98%) | -2.09 (18.36%) | -2.56 (20.74%) | -3.23 (-11.00%) |
Sales Per Share (SPS) | 5.09 (-2.88%) | 5.25 (2.00%) | 5.14 (0.94%) | 5.09 (6.66%) |
Free Cash Flow Per Share (FCFPS) | -0.02 (97.32%) | -0.82 (12.58%) | -0.94 (-10.87%) | -0.85 (5.37%) |
Book Value Per Share (BVPS) | 6.07 (-6.70%) | 6.5 (-17.79%) | 7.91 (-28.04%) | 10.99 (57.43%) |
Tangible Assets Book Value Per Share (TABVPS) | 8.53 (9.87%) | 7.76 (-12.07%) | 8.82 (-24.80%) | 11.73 (25.07%) |
Enterprise Value Over EBIT (EV/EBIT) | -7 (-40.00%) | -5 (0.00%) | -5 (64.29%) | -14 (22.22%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -18.15 (-115.70%) | -8.41 (-5.44%) | -7.98 (58.86%) | -19.39 (18.05%) |
Asset Turnover | 0.4 (-2.20%) | 0.41 (11.72%) | 0.37 (26.12%) | 0.29 (-11.01%) |
Current Ratio | 1.43 (-67.66%) | 4.42 (-14.77%) | 5.18 (-5.11%) | 5.46 (45.86%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$1,318,000 (97.15%) | -$46,242,000 (8.24%) | -$50,395,000 (-25.38%) | -$40,195,000 (-13.70%) |
Enterprise Value (EV) | $466,197,942 (-32.16%) | $687,235,000 (-2.65%) | $705,976,513 (-64.50%) | $1,988,748,709 (2.96%) |
Earnings Before Tax (EBT) | -$69,169,000 (41.28%) | -$117,791,000 (16.86%) | -$141,683,000 (11.51%) | -$160,108,000 (-37.77%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$25,690,000 (68.55%) | -$81,684,000 (7.68%) | -$88,477,000 (13.71%) | -$102,537,000 (-25.64%) |
Invested Capital | $339,888,000 (-30.85%) | $491,536,000 (-6.06%) | $523,267,000 (10.01%) | $475,669,000 (23.14%) |
Working Capital | $139,800,000 (-54.07%) | $304,363,000 (-11.85%) | $345,285,000 (-16.87%) | $415,340,000 (71.80%) |
Tangible Asset Value | $513,118,000 (17.21%) | $437,778,000 (-7.66%) | $474,115,000 (-14.93%) | $557,336,000 (50.23%) |
Market Capitalization | $430,192,942 (-19.28%) | $532,916,000 (-8.43%) | $582,003,513 (-71.78%) | $2,062,430,709 (11.49%) |
Average Equity | $358,614,000 (-7.11%) | $386,081,500 (-9.16%) | $425,010,000 (-18.60%) | $522,098,000 (89.10%) |
Average Assets | $764,702,750 (5.84%) | $722,484,500 (-3.96%) | $752,286,000 (-9.59%) | $832,096,000 (44.03%) |
Invested Capital Average | $273,815,250 (-45.65%) | $503,794,750 (-3.72%) | $523,267,000 (10.01%) | $475,669,000 (23.14%) |
Shares | 60,847,658 (5.73%) | 57,550,324 (5.11%) | 54,751,036 (5.18%) | 52,055,293 (22.49%) |
